HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas

C. C. Uphoff, S. Habig, A. Carbone, G. Caidano, H. G. Drexler

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Human herpes virus 8 (HHV-8; or KSHV, Kaposi's sarcoma-associated herpes virus) is a gamma herpes virus with sequence homology to Epstein-Barr virus (EBV). It was first isolated from Kaposi's sarcoma tumor cells and subsequently from tumor cells and peripheral blood mononuclear cells from patients with primary effusion lymphomas (PEL; or body cavity-based lymphomas). PEL has been recognized as an individual nosologic entity based on its distinctive biological-pathological features and its consistent infection with HHV-8 (commonly, but not always co-infected with EBV), occurring predominantly in human immunodeficiency virus (HIV)-infected patients but occasionally also in HIV-negative cases. Whether HHV-8 sequences can be found also in non-hematopoietic tumor cells other than Kaposi's sarcoma and in malignant hematopoietic malignancies other than PEL, has been the focus of the present studies. We examined the presence of HHV-8 sequences by polymerase chain reaction (PCR) using (1) a panel of 133 human cell lines established from a large variety of solid tumors; (2) a spectrum of 114 hematopoietic cell lines derived from the different cell lineages including 50 B cell leukemia/lymphoma-derived cell lines and seven cell lines established from patients with PEL. Besides the seven PEL cell lines, 46 cell lines that were derived from malignant pleural effusion or ascitic fluid material (25 non-hematopoietic and 21 hematopoietic cell lines) were examined. Except for the seven PEL cell lines that were strongly HHV-8+ in the PCR, all solid tumor cell lines and all hematopoietic cell lines scored consistently negative for the presence of HHV-8 sequences. These results confirm the absolute specificity of HHV-8 infection (within the hematopoietic malignancies) for PEL. PEL cell lines represent useful tools for the analysis of the biology of this neoplasm and of the pathogenetic role of the virus in the disease development.

Original languageEnglish
Pages (from-to)1806-1809
Number of pages4
JournalLeukemia
Volume12
Issue number11
Publication statusPublished - 1998

Fingerprint

Human Herpesvirus 8
Lymphoma
Cell Line
Infection
Kaposi's Sarcoma
Hematologic Neoplasms
Neoplasms
Human Herpesvirus 4
Primary Effusion Lymphoma
HIV
B-Cell Leukemia
Malignant Pleural Effusion
Viruses
Satellite Viruses
Polymerase Chain Reaction
Ascitic Fluid
B-Cell Lymphoma
Cell Lineage
Virus Diseases
Sequence Homology

Keywords

  • Body cavity-based lymphoma
  • EBV
  • HHV-8
  • HIV
  • Primary effusion lymphoma
  • Viruses

ASJC Scopus subject areas

  • Cancer Research
  • Hematology

Cite this

Uphoff, C. C., Habig, S., Carbone, A., Caidano, G., & Drexler, H. G. (1998). HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas. Leukemia, 12(11), 1806-1809.

HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas. / Uphoff, C. C.; Habig, S.; Carbone, A.; Caidano, G.; Drexler, H. G.

In: Leukemia, Vol. 12, No. 11, 1998, p. 1806-1809.

Research output: Contribution to journalArticle

Uphoff, CC, Habig, S, Carbone, A, Caidano, G & Drexler, HG 1998, 'HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas', Leukemia, vol. 12, no. 11, pp. 1806-1809.
Uphoff CC, Habig S, Carbone A, Caidano G, Drexler HG. HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas. Leukemia. 1998;12(11):1806-1809.
Uphoff, C. C. ; Habig, S. ; Carbone, A. ; Caidano, G. ; Drexler, H. G. / HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas. In: Leukemia. 1998 ; Vol. 12, No. 11. pp. 1806-1809.
@article{eed8d6d4144d4d4092988c22ff882603,
title = "HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas",
abstract = "Human herpes virus 8 (HHV-8; or KSHV, Kaposi's sarcoma-associated herpes virus) is a gamma herpes virus with sequence homology to Epstein-Barr virus (EBV). It was first isolated from Kaposi's sarcoma tumor cells and subsequently from tumor cells and peripheral blood mononuclear cells from patients with primary effusion lymphomas (PEL; or body cavity-based lymphomas). PEL has been recognized as an individual nosologic entity based on its distinctive biological-pathological features and its consistent infection with HHV-8 (commonly, but not always co-infected with EBV), occurring predominantly in human immunodeficiency virus (HIV)-infected patients but occasionally also in HIV-negative cases. Whether HHV-8 sequences can be found also in non-hematopoietic tumor cells other than Kaposi's sarcoma and in malignant hematopoietic malignancies other than PEL, has been the focus of the present studies. We examined the presence of HHV-8 sequences by polymerase chain reaction (PCR) using (1) a panel of 133 human cell lines established from a large variety of solid tumors; (2) a spectrum of 114 hematopoietic cell lines derived from the different cell lineages including 50 B cell leukemia/lymphoma-derived cell lines and seven cell lines established from patients with PEL. Besides the seven PEL cell lines, 46 cell lines that were derived from malignant pleural effusion or ascitic fluid material (25 non-hematopoietic and 21 hematopoietic cell lines) were examined. Except for the seven PEL cell lines that were strongly HHV-8+ in the PCR, all solid tumor cell lines and all hematopoietic cell lines scored consistently negative for the presence of HHV-8 sequences. These results confirm the absolute specificity of HHV-8 infection (within the hematopoietic malignancies) for PEL. PEL cell lines represent useful tools for the analysis of the biology of this neoplasm and of the pathogenetic role of the virus in the disease development.",
keywords = "Body cavity-based lymphoma, EBV, HHV-8, HIV, Primary effusion lymphoma, Viruses",
author = "Uphoff, {C. C.} and S. Habig and A. Carbone and G. Caidano and Drexler, {H. G.}",
year = "1998",
language = "English",
volume = "12",
pages = "1806--1809",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas

AU - Uphoff, C. C.

AU - Habig, S.

AU - Carbone, A.

AU - Caidano, G.

AU - Drexler, H. G.

PY - 1998

Y1 - 1998

N2 - Human herpes virus 8 (HHV-8; or KSHV, Kaposi's sarcoma-associated herpes virus) is a gamma herpes virus with sequence homology to Epstein-Barr virus (EBV). It was first isolated from Kaposi's sarcoma tumor cells and subsequently from tumor cells and peripheral blood mononuclear cells from patients with primary effusion lymphomas (PEL; or body cavity-based lymphomas). PEL has been recognized as an individual nosologic entity based on its distinctive biological-pathological features and its consistent infection with HHV-8 (commonly, but not always co-infected with EBV), occurring predominantly in human immunodeficiency virus (HIV)-infected patients but occasionally also in HIV-negative cases. Whether HHV-8 sequences can be found also in non-hematopoietic tumor cells other than Kaposi's sarcoma and in malignant hematopoietic malignancies other than PEL, has been the focus of the present studies. We examined the presence of HHV-8 sequences by polymerase chain reaction (PCR) using (1) a panel of 133 human cell lines established from a large variety of solid tumors; (2) a spectrum of 114 hematopoietic cell lines derived from the different cell lineages including 50 B cell leukemia/lymphoma-derived cell lines and seven cell lines established from patients with PEL. Besides the seven PEL cell lines, 46 cell lines that were derived from malignant pleural effusion or ascitic fluid material (25 non-hematopoietic and 21 hematopoietic cell lines) were examined. Except for the seven PEL cell lines that were strongly HHV-8+ in the PCR, all solid tumor cell lines and all hematopoietic cell lines scored consistently negative for the presence of HHV-8 sequences. These results confirm the absolute specificity of HHV-8 infection (within the hematopoietic malignancies) for PEL. PEL cell lines represent useful tools for the analysis of the biology of this neoplasm and of the pathogenetic role of the virus in the disease development.

AB - Human herpes virus 8 (HHV-8; or KSHV, Kaposi's sarcoma-associated herpes virus) is a gamma herpes virus with sequence homology to Epstein-Barr virus (EBV). It was first isolated from Kaposi's sarcoma tumor cells and subsequently from tumor cells and peripheral blood mononuclear cells from patients with primary effusion lymphomas (PEL; or body cavity-based lymphomas). PEL has been recognized as an individual nosologic entity based on its distinctive biological-pathological features and its consistent infection with HHV-8 (commonly, but not always co-infected with EBV), occurring predominantly in human immunodeficiency virus (HIV)-infected patients but occasionally also in HIV-negative cases. Whether HHV-8 sequences can be found also in non-hematopoietic tumor cells other than Kaposi's sarcoma and in malignant hematopoietic malignancies other than PEL, has been the focus of the present studies. We examined the presence of HHV-8 sequences by polymerase chain reaction (PCR) using (1) a panel of 133 human cell lines established from a large variety of solid tumors; (2) a spectrum of 114 hematopoietic cell lines derived from the different cell lineages including 50 B cell leukemia/lymphoma-derived cell lines and seven cell lines established from patients with PEL. Besides the seven PEL cell lines, 46 cell lines that were derived from malignant pleural effusion or ascitic fluid material (25 non-hematopoietic and 21 hematopoietic cell lines) were examined. Except for the seven PEL cell lines that were strongly HHV-8+ in the PCR, all solid tumor cell lines and all hematopoietic cell lines scored consistently negative for the presence of HHV-8 sequences. These results confirm the absolute specificity of HHV-8 infection (within the hematopoietic malignancies) for PEL. PEL cell lines represent useful tools for the analysis of the biology of this neoplasm and of the pathogenetic role of the virus in the disease development.

KW - Body cavity-based lymphoma

KW - EBV

KW - HHV-8

KW - HIV

KW - Primary effusion lymphoma

KW - Viruses

UR - http://www.scopus.com/inward/record.url?scp=0031786595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031786595&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 1806

EP - 1809

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 11

ER -